Partner-Specific Drug Repositioning Approach Based on Graph Convolutional Network
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Partner-Specific Drug Repositioning Approach Based on Graph Convolutional Network
Authors
Keywords
-
Journal
IEEE Journal of Biomedical and Health Informatics
Volume 26, Issue 11, Pages 5757-5765
Publisher
Institute of Electrical and Electronics Engineers (IEEE)
Online
2022-08-04
DOI
10.1109/jbhi.2022.3194891
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A weighted bilinear neural collaborative filtering approach for drug repositioning
- (2022) Yajie Meng et al. BRIEFINGS IN BIOINFORMATICS
- Drug repositioning based on multi-view learning with matrix completion
- (2022) Yixin Yan et al. BRIEFINGS IN BIOINFORMATICS
- Pharmaco-transcriptomic correlation analysis reveals novel responsive signatures to HDAC inhibitors and identifies Dasatinib as a synergistic interactor in small-cell lung cancer
- (2021) Haitang Yang et al. EBioMedicine
- Biomedical data and computational models for drug repositioning: a comprehensive review
- (2020) Huimin Luo et al. BRIEFINGS IN BIOINFORMATICS
- Coronavirus puts drug repurposing on the fast track
- (2020) Charlotte Harrison NATURE BIOTECHNOLOGY
- iDrug: Integration of drug repositioning and drug-target prediction via cross-network embedding
- (2020) Huiyuan Chen et al. PLoS Computational Biology
- Predicting drug–disease associations through layer attention graph convolutional network
- (2020) Zhouxin Yu et al. BRIEFINGS IN BIOINFORMATICS
- Comparative Toxicogenomics Database (CTD): update 2021
- (2020) Allan Peter Davis et al. NUCLEIC ACIDS RESEARCH
- deepDR: A network-based deep learning approach to in silico drug repositioning
- (2019) Xiangxiang Zeng et al. BIOINFORMATICS
- Phase II study of irinotecan and temozolomide in breast cancer patients with progressing central nervous system disease
- (2019) Michelle E. Melisko et al. BREAST CANCER RESEARCH AND TREATMENT
- Convolutional Neural Network and Bidirectional Long Short-Term Memory-Based Method for Predicting Drug–Disease Associations
- (2019) Xuan et al. Cells
- β-2-Himachalen-6-ol inhibits 4T1 cells-induced metastatic triple negative breast carcinoma in murine model
- (2019) Hamid E. Daaboul et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Neural inductive matrix completion with graph convolutional networks for miRNA-disease association prediction
- (2019) Jin Li et al. BIOINFORMATICS
- Predicting drug-disease associations with heterogeneous network embedding
- (2019) Kai Yang et al. CHAOS
- NeoDTI: Neural integration of neighbor information from a heterogeneous network for discovering new drug-target interactions
- (2018) Fangping Wan et al. BIOINFORMATICS
- Predicting drug-disease associations by using similarity constrained matrix factorization
- (2018) Wen Zhang et al. BMC BIOINFORMATICS
- Octreotide-modified liposomes containing daunorubicin and dihydroartemisinin for treatment of invasive breast cancer
- (2018) Rui-Jun Ju et al. Artificial Cells Nanomedicine and Biotechnology
- NGR‐hTNF and Doxorubicin as Second‐Line Treatment of Patients with Small Cell Lung Cancer
- (2018) Vanesa Gregorc et al. ONCOLOGIST
- Drug repurposing: progress, challenges and recommendations
- (2018) Sudeep Pushpakom et al. NATURE REVIEWS DRUG DISCOVERY
- Drug-Target Interaction Prediction with Graph Regularized Matrix Factorization
- (2017) Ali Ezzat et al. IEEE-ACM Transactions on Computational Biology and Bioinformatics
- Redox-triggered mitoxantrone prodrug micelles for overcoming multidrug-resistant breast cancer
- (2017) Hongzhi Qiao et al. JOURNAL OF DRUG TARGETING
- Drug repositioning based on comprehensive similarity measures and Bi-Random walk algorithm
- (2016) Huimin Luo et al. BIOINFORMATICS
- The Comparative Toxicogenomics Database: update 2017
- (2016) Allan Peter Davis et al. NUCLEIC ACIDS RESEARCH
- Neighborhood Regularized Logistic Matrix Factorization for Drug-Target Interaction Prediction
- (2016) Yong Liu et al. PLoS Computational Biology
- Medical subject headings (MeSH) terms
- (2014) IshKumar Dhammi et al. Indian Journal of Orthopaedics
- Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer
- (2012) Charles M Rudin et al. NATURE GENETICS
- Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
- (2012) Martin Peifer et al. NATURE GENETICS
- PREDICT: a method for inferring novel drug indications with application to personalized medicine
- (2011) A. Gottlieb et al. Molecular Systems Biology
- Simultaneous liposomal delivery of quercetin and vincristine for enhanced estrogen-receptor-negative breast cancer treatment
- (2010) Man-Yi Wong et al. ANTI-CANCER DRUGS
- A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin and paclitaxel in patients with advanced cancer
- (2010) G J Rustin et al. BRITISH JOURNAL OF CANCER
- Impact of High-Dose Chemotherapy on the Ability to Deliver Subsequent Local–Regional Radiotherapy for Breast Cancer: Analysis of Cancer and Leukemia Group B Protocol 9082
- (2009) Lawrence B. Marks et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now